| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Chemomab Therapeutics Ltd. | Chief Financial Officer | American Depositary Shares | 5,209 | $26,185 | $5.03 | 14 Jun 2023 | Direct |
| Chemomab Therapeutics Ltd. | Chief Financial Officer | Option to Purchase American Depositary Shares | 35,600 | 11 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd. | 14 Jun 2023 | 3 | $0 | 4 | Chief Financial Officer | 16 Jun 2023, 16:03 |
| CMMB | Chemomab Therapeutics Ltd. | 01 Jun 2023 | 0 | $0 | 3 | Chief Financial Officer | 05 Jun 2023, 16:54 |
| CMMB | Chemomab Therapeutics Ltd. | 07 May 2021 | 1 | $0 | 4 | Chief Financial Officer | 10 May 2021, 16:01 |